Clinical Trials Directory

Trials / Unknown

UnknownNCT04894604

A Safety and Performance PMCF Investigation of the Avance® Solo NPWT System in Surgically Closed Incisions

A Prospective, Open, Non-comparative, Post-Market Clinical Follow-up Investigation to Confirm the Safety and Performance of Avance® Solo NPWT System in Surgically Closed Incisions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Molnlycke Health Care AB · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The ASOLO-SCI investigation is a Post Market Clinical Follow-up (PMCF) study to investigate the safety and performance of the Avance® Solo NPWT System in treating low to moderate exuding surgically closed incisions for up to 14 days when used in accordance with the Instructions for Use (IfU).

Detailed description

The ASOLO-SCI investigation is designed as a prospective, open, non-comparative, PMCF study to investigate the safety and performance of the Avance® Solo NPWT System in treating low to moderate exuding surgically closed incisions for up to 14 days when used in accordance with the IfU in up to 34 patients (n=34). The ASOLO-SCI investigation is a multicentre study that is expected to take place in approximately three European centres. The study treatment shall be stopped earlier (i.e. prior to 14 days), in the event study Subjects withdraw their consent, or shall the Principal Investigator and clinical team deem the Avance® Solo NPWT System to be no longer adequate for the study Subject's wound. Following termination of Subject participation for whichever reason in the study, the patient shall be followed in accordance with the local standard of care in wound management and treatment. As a primary endpoint, the Principal Investigator and clinical team will evaluate whether the surgical incision remains closed, from baseline to study end at Day 14.

Conditions

Interventions

TypeNameDescription
DEVICEAvance® Solo NPWT SystemApplication of the Avance® Solo NPWT System on up to 34 study Subjects, in accordance with the IfU for up to 14 days.

Timeline

Start date
2021-06-30
Primary completion
2022-02-28
Completion
2022-03-31
First posted
2021-05-20
Last updated
2021-05-20

Source: ClinicalTrials.gov record NCT04894604. Inclusion in this directory is not an endorsement.